Nomura Recap of Stocks to Look Out For
February 19, 2015 at 20:01 PM EST
Analyst M. Ian Somaiya at Nomura upgraded Pharmacyclics (NASDAQ: PCYC) from Neutral to Buy, while raising the price target from $195 to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.